Accuray Inc (ARAY)
1.79
+0.04
(+2.29%)
USD |
NASDAQ |
Nov 04, 13:04
Accuray Revenue (Quarterly): 134.29M for June 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 134.29M |
| March 31, 2024 | 101.13M |
| December 31, 2023 | 107.24M |
| September 30, 2023 | 103.89M |
| June 30, 2023 | 118.29M |
| March 31, 2023 | 118.06M |
| December 31, 2022 | 114.76M |
| September 30, 2022 | 96.49M |
| June 30, 2022 | 110.02M |
| March 31, 2022 | 96.17M |
| December 31, 2021 | 116.28M |
| September 30, 2021 | 107.44M |
| June 30, 2021 | 110.94M |
| March 31, 2021 | 102.56M |
| December 31, 2020 | 97.46M |
| September 30, 2020 | 85.33M |
| June 30, 2020 | 94.98M |
| March 31, 2020 | 99.55M |
| December 31, 2019 | 98.83M |
| September 30, 2019 | 89.58M |
| June 30, 2019 | 117.42M |
| March 31, 2019 | 103.22M |
| December 31, 2018 | 102.32M |
| September 30, 2018 | 95.83M |
| June 30, 2018 | 113.79M |
| Date | Value |
|---|---|
| March 31, 2018 | 99.83M |
| December 31, 2017 | 100.33M |
| September 30, 2017 | 90.95M |
| June 30, 2017 | 112.09M |
| March 31, 2017 | 97.31M |
| December 31, 2016 | 87.50M |
| September 30, 2016 | 86.51M |
| June 30, 2016 | 94.97M |
| March 31, 2016 | 105.28M |
| December 31, 2015 | 108.91M |
| September 30, 2015 | 89.63M |
| June 30, 2015 | 101.75M |
| March 31, 2015 | 97.52M |
| December 31, 2014 | 98.16M |
| September 30, 2014 | 82.38M |
| June 30, 2014 | 102.00M |
| March 31, 2014 | 97.14M |
| December 31, 2013 | 93.63M |
| September 30, 2013 | 76.64M |
| June 30, 2013 | 84.90M |
| March 31, 2013 | 70.55M |
| December 31, 2012 | 77.78M |
| September 30, 2012 | 82.75M |
| June 30, 2012 | 100.53M |
| March 31, 2012 | 101.82M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
85.33M
Minimum
Sep 2020
134.29M
Maximum
Jun 2024
105.98M
Average
103.89M
Median
Sep 2023
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Baxter International Inc | 3.812B |
| AngioDynamics Inc | 67.49M |
| Masimo Corp | 496.30M |
| Perspective Therapeutics Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.387M |
| Total Expenses (Quarterly) | 127.47M |
| EPS Diluted (Quarterly) | 0.03 |
| Enterprise Value | 279.05M |
| Gross Profit Margin (Quarterly) | 28.63% |
| Profit Margin (Quarterly) | 2.52% |
| Earnings Yield | -8.94% |
| Operating Earnings Yield | 0.29% |
| Normalized Earnings Yield | -7.976 |